Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive phase II/III crossover study of intracerebral neural stem cell transplantation for post-ischemic stroke paralysis
ChiCTR1800014354Phase 2Recruiting
- Sponsor
- Philippine Army General Hospital
- Start
- Jan 2018
- Modality
- Neural Stem Cells → Tissue-Specific Stem Cells → Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of NSI-566 in ischemic stroke (2 arms), sponsored by Philippine Army General Hospital. Primary endpoints: vital signs, treatment-emergent adverse events and 4 more. Started Jan 2018; status: recruiting.
02
Drugs
NSI-566
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR1800014354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014354.